Industry Sessions

2 May 2021

2 May 2021, 17:00 – 18:30

Merz Therapeutics
Expert Perspectives: A First-Line Treatment for Chronic Sialorrhea and Why Immunogenicity Matters with Botulinum Toxin

2 May 2021, 17:00 – 18:30

Sunovion
Navigating the Treatment Options for “OFF” Episodes in Parkinson’s Disease: The Role of On-Demand Treatments

3 May 2021

3 May 2021, 16:45 – 18:15

Industry Session by Sunovion

3 May 2021, 16:45 – 18:15 

Britannia Pharmaceuticals LTD
Lifting the burden of advanced Parkinson’s – progress in device-aided therapies

Status: 09.04.2021. Program subject to change.